These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17503736)

  • 1. The pivotal role of RhoA GTPase in the molecular signaling of axon growth inhibition after CNS injury and targeted therapeutic strategies.
    Gross RE; Mei Q; Gutekunst CA; Torre E
    Cell Transplant; 2007; 16(3):245-62. PubMed ID: 17503736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of RhoA in retrograde neuronal death and axon regeneration after spinal cord injury.
    Hu J; Zhang G; Rodemer W; Jin LQ; Shifman M; Selzer ME
    Neurobiol Dis; 2017 Feb; 98():25-35. PubMed ID: 27888137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated RHOA and peripheral axon regeneration.
    Cheng C; Webber CA; Wang J; Xu Y; Martinez JA; Liu WQ; McDonald D; Guo GF; Nguyen MD; Zochodne DW
    Exp Neurol; 2008 Aug; 212(2):358-69. PubMed ID: 18554585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelin-associated inhibitors of axon regeneration.
    Grados-Munro EM; Fournier AE
    J Neurosci Res; 2003 Nov; 74(4):479-85. PubMed ID: 14598291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citron kinase regulates axon growth through a pathway that converges on cofilin downstream of RhoA.
    Ahmed Z; Douglas MR; Read ML; Berry M; Logan A
    Neurobiol Dis; 2011 Feb; 41(2):421-9. PubMed ID: 20971191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RhoA drives actin compaction to restrict axon regeneration and astrocyte reactivity after CNS injury.
    Stern S; Hilton BJ; Burnside ER; Dupraz S; Handley EE; Gonyer JM; Brakebusch C; Bradke F
    Neuron; 2021 Nov; 109(21):3436-3455.e9. PubMed ID: 34508667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition.
    Alabed YZ; Pool M; Ong Tone S; Fournier AE
    J Neurosci; 2007 Feb; 27(7):1702-11. PubMed ID: 17301178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3 transferase gene therapy for continuous conditional RhoA inhibition.
    Gutekunst CA; Tung JK; McDougal ME; Gross RE
    Neuroscience; 2016 Dec; 339():308-318. PubMed ID: 27746349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanism and regulation of axon growth inhibition].
    Yamashita T
    Brain Nerve; 2007 Dec; 59(12):1347-53. PubMed ID: 18095484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drugs promote axon regeneration via RhoA inhibition.
    Fu Q; Hue J; Li S
    J Neurosci; 2007 Apr; 27(15):4154-64. PubMed ID: 17428993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system regeneration inhibitors and their intracellular substrates.
    Nash M; Pribiag H; Fournier AE; Jacobson C
    Mol Neurobiol; 2009 Dec; 40(3):224-35. PubMed ID: 19763907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to neutralize RhoA/ROCK pathway after spinal cord injury.
    Roy A; Pathak Z; Kumar H
    Exp Neurol; 2021 Sep; 343():113794. PubMed ID: 34166685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration.
    Sandvig A; Berry M; Barrett LB; Butt A; Logan A
    Glia; 2004 May; 46(3):225-51. PubMed ID: 15048847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular approaches to spinal cord repair.
    David S; Lacroix S
    Annu Rev Neurosci; 2003; 26():411-40. PubMed ID: 12626698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-glycan antibodies halt axon regeneration in a model of Guillain Barrè Syndrome axonal neuropathy by inducing microtubule disorganization via RhoA-ROCK-dependent inactivation of CRMP-2.
    Rozés Salvador V; Heredia F; Berardo A; Palandri A; Wojnacki J; Vivinetto AL; Sheikh KA; Caceres A; Lopez PH
    Exp Neurol; 2016 Apr; 278():42-53. PubMed ID: 26804001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling mechanisms of axon growth inhibition.
    Hata K; Kubo T; Yamaguchi A; Yamashita T
    Drug News Perspect; 2006 Nov; 19(9):541-7. PubMed ID: 17220959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Rho-kinase differentially affects axon regeneration of peripheral motor and sensory nerves.
    Joshi AR; Bobylev I; Zhang G; Sheikh KA; Lehmann HC
    Exp Neurol; 2015 Jan; 263():28-38. PubMed ID: 25261755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS axon regeneration inhibitors stimulate an immediate early gene response via MAP kinase-SRF signaling.
    Stern S; Knöll B
    Mol Brain; 2014 Nov; 7():86. PubMed ID: 25406759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small Nogo-66-binding peptide promotes neurite outgrowth through RhoA inhibition after spinal cord injury.
    Deng Q; Cai W; Li S; Zhang Y; Su B
    Brain Res Bull; 2013 Oct; 99():140-4. PubMed ID: 24184005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axon regeneration: it's getting crowded at the gates of TROY.
    Mandemakers WJ; Barres BA
    Curr Biol; 2005 Apr; 15(8):R302-5. PubMed ID: 15854897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.